drugset / Trial / NCT00177398

Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings

NCT00177398

Phase 4 Completed 50 enrolled University of Pittsburgh Sanofi · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if the early initiation of a long acting insulin (i.e. glargine) with supplemental doses of short acting regular (SSR) insulin in hospitalized patients with diabetes who are fed using tube feedings reduces the frequency of high and low blood sugar levels when compared to use of SSR insulin alone.

Timeline

Start
2005-02
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic Subcutaneous
Background Insulin Protein / enzyme biologic Subcutaneous